How good patient blood management leads to excellent outcomes in Jehovah's witness patients undergoing cardiac surgery

Interactive Cardiovascular and Thoracic Surgery

Volumn 12, Issue 2, 2011, Pages 183-188

  Emmert, Maximilian Y ^a   Salzberg, Sacha P ^a   Theusinger, Oliver M ^a   Felix, Christian ^a   Plass, Andre ^a   Hoerstrup, Simon P ^a   Falk, Volkmar ^a   Gruenenfelder, Juerg ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cardiac surgery; Jehovah's witnesses; Off pump surgery; Patient blood management

Indexed keywords

ACETYLSALICYLIC ACID; ARISTA; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BONE WAX; CLOPIDOGREL; COSEAL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; FIBRIN GLUE; HEMOGLOBIN; HETASTARCH; IRON COMPLEX; PHENPROCOUMON; PLASMA SUBSTITUTE; RINGER LACTATE SOLUTION; TABOTAMP NU KNIT; TISSUCOL DUO S; UNCLASSIFIED DRUG; VIVOSTAT;

ADULT; AORTA DISSECTION; AORTA SURGERY; ARTICLE; BODY MASS; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; HEART EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBINOPATHY; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; JEHOVAH'S WITNESS; LENGTH OF STAY; MALE; OFF PUMP CORONARY SURGERY; OPERATION DURATION; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURGICAL APPROACH; THROMBOCYTE COUNT;

AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; DATABASES, FACTUAL; FEMALE; FLUID THERAPY; FOLLOW-UP STUDIES; HEMODYNAMICS; HUMANS; JEHOVAH'S WITNESSES; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PREOPERATIVE CARE; RELIGION AND MEDICINE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 79551602301     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2010.242552     Document Type: Article

References (25)

1. Ridley DT. Jehovah's Witnesses' refusal of blood: obedience to scriptureand religious conscience. J Med Ethics 1999;25:469-472.
2. Remmers PA, Speer AJ. Clinical strategies in the medical care ofJehovah's Witnesses. Am J Med 2006;119:1013-1018.
3. Ascione R, Williams S, Lloyd CT, Sundaramoorthi T, Pitsis AA, Angelini GD. Reduced postoperative blood loss and transfusion requirementafter beating-heart coronary operations: a prospective randomizedstudy. J Thorac Cardiovasc Surg 2001;121:689-696.
4. Stamou SC, White T, Barnett S, Boyce SW, Corso PJ, Lefrak EA. Comparisons of cardiac surgery outcomes in Jehovah's versus Non-Jehovah's Witnesses. Am J Cardiol 2006;98:1223-1225.
5. Juraszek A, Dziodzio T, Roedler S, Kral A, Hutschala D, Wolner E, Grimm M, Czerny M. Results of open heart surgery in Jehovah's Witnessespatients. J Cardiovasc Surg (Torino) 2009;50:247-250.
6. Ott DA, Cooley DA. Cardiovascular surgery in Jehovah's Witnesses. Report of 542 operations without blood transfusion. JAMA 1977;238:1256-1258.
7. Rosengart TK, Helm RE, DeBois WJ, Garcia N, Krieger KH, Isom OW. Open heart operations without transfusion using a multimodality bloodconservation strategy in 50 Jehovah's Witness patients: implications fora ''bloodless'' surgical technique. J Am Coll Surg 1997;184:618-629.
8. Rosengart TK, Lang S, Helm R, Friedman D. Open heart surgery in thepediatric Jehovah's Witness population: no longer ''Russian roulette''. Pediatr Cardiol 1997;18:245-246.
9. Reeves BC, Murphy GJ. Increased mortality, morbidity, and cost associatedwith red blood cell transfusion after cardiac surgery. Curr OpinAnaesthesiol 2008;21:669-673.
10. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients atfour hospitals. Transfusion 2010;50:753-765. Epub 2009 Dec 9.
11. Walther T, Falk V, Mohr FW. Minimally invasive surgery for valve disease. Curr Probl Cardiol 2006;31:399-437.
12. Cleveland JC Jr, Shroyer AL, Chen AY, Peterson E, Grover FL. Off-pumpcoronary artery bypass grafting decreases risk-adjusted mortality andmorbidity. Ann Thorac Surg 2001;72:1282-1288; discussion 1288-1289.
13. Hannan EL, Wu C, Smith CR, Higgins RS, Carlson RE, Culliford AT, Gold JP, Jones RH. Off-pump versus on-pump coronary artery bypass graftsurgery: differences in short-term outcomes and in long-term mortalityand need for subsequent revascularization. Circulation 2007;116:1145-1152.
14. Helm RE, Rosengart TK, Gomez M, Klemperer JD, DeBois WJ, Velasco F, Gold JP, Altorki NK, Lang S, Thomas S, Isom OW, Krieger KH. Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. Ann Thorac Surg 1998;65:125-136.
15. Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence andoutcomes of anemia in surgery: a systematic review of the literature. Am J Med 2004;116(Suppl 7A):58S-69S.
16. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-1023.
17. Goodnough LT. Erythropoietin and iron-restricted erythropoiesis. ExpHematol 2007;35(Suppl 1):167-172.
18. Theusinger OM, Spahn DR, Ganter MT. Transfusion in trauma: why andhow should we change our current practice? Curr Opin Anaesthesiol 2009;22:305-312.
19. Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir MT, Doss M, Borger MA, Schuler G, Glogar D, Fehske W, Wolner E, Mohr FW, Mack M. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007;116(Suppl 11):I240-I245.
20. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aorticvalve replacement. J Am Coll Cardiol 2009;53:1829-1836.
21. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrmann HC, Lim S, Foster E, Glower D. Percutaneousmitral repair with the MitraClip system: safety and midtermdurability in the initial EVEREST (Endovascular Valve Edge-to-EdgeREpair Study) cohort. J Am Coll Cardiol 2009;54:686-694.
22. Beris P, Munoz M, Garcia-Erce JA, Thomas D, Maniatis A, Van der Linden P. Perioperative anaemia management: consensus statement on therole of intravenous iron. Br J Anaesth 2008;100:599-604.
23. Niranjan G, Asimakopoulos G, Karagounis A, Cockerill G, Thompson M, Chandrasekaran V. Effects of cell saver autologous blood transfusion onblood loss and homologous blood transfusion requirements in patientsundergoing cardiac surgery on- versus off-cardiopulmonary bypass: arandomised trial. Eur J Cardiothorac Surg 2006;30:271-277.
24. Schuller D, Mitchell JP, Calandrino FS, Schuster DP. Fluid balance duringpulmonary edema. Is fluid gain a marker or a cause of poor outcome? Chest 1991;100:1068-1075.
25. Haas T, Fries D, Velik-Salchner C, Reif C, Klingler A, Innerhofer P. Thein vitro effects of fibrinogen concentrate, factor XIII and fresh frozenplasma on impaired clot formation after 60% dilution. Anesth Analg 2008;106:1360-1365, table of contents.